Abstract:Four-membered heterocycles such as oxetanes and azetidines represent attractive and emergent design options in medicinal chemistry due to their small and polar nature, and potential to significantly impact physiochemical properties of drug molecules. The challenging preparation of these derivatives, especially in a divergent manner, has severely limited the combination of oxetanes with other medicinally and biologically important groups. Consequently, there is a substantial demand for mild and effective synthetic strategies to access new oxetane and azetidine derivatives and molecular scaffolds. Herein, we report the development and use of oxetane sulfonyl fluorides (OSF) and azetidine sulfonyl fluorides (ASF), which behave as precursors to carbocations in an unusual defluorosulfonylation reaction pathway (deFS). The small-ring sulfonyl fluorides are activated under mild thermal conditions (60 ºC), and the generated reactive intermediates couple with a broad range of nucleophiles. This reactivity enables the generation of new chemical motifs that make attractive design elements for drug discovery. Notably, oxetane and azetidine-heterocyclic, -sulfoximine and -phosphonate derivatives are prepared, several of which do not have comparable carbonyl analogues. Alternatively, a SuFEx pathway under anionic conditions accesses oxetane-sulfur (VI) derivatives. We demonstrate the synthetic utility of novel OSF and ASF reagents through the synthesis of 11 drug analogues, showcasing their potential for subsequent diversification and facile inclusion into medicinal chemistry programs. Moreover, we propose the application of the OSF and ASF reagents as linker motifs and demonstrate the incorporation of pendant groups suitable for common conjugation reactions. Productive deFS reactions with E3 ligase recruiters such as pomalidomide and related derivatives provide new degrader motifs, and potential PROTAC linkers.

A new synthetic route towards multifunctionalized cyclic amidrazones for feeding chemical space

Diastereo‐ and Enantioselective Silver‐Catalyzed [3+3] Cycloaddition and Kinetic Resolution of Azomethine Imines with Activated Isocyanides

Diversified Ring Expansion of Saturated Cyclic Amines Enabled by Azlactone Insertion

Innovative synthesis of drug-like molecules using tetrazole as core building blocks

Synthesis of Complex Tetracyclic Fused Scaffolds Enabled by (3 + 2) Cycloaddition

Modular Access to Functionalized Azetidines via Electrophilic Azetidinylation

Synthesis of polysubstituted azepanes by dearomative ring expansion of nitroarenes

A short scalable route to bis-morpholine spiroacetals and oxazepane analogues: useful 3D-scaffolds for compound library assembly

Synthesis of Fused [1,2,3]-Triazoloheteroarenes via Intramolecular Azo Annulation of N -Tosylhydrazones Catalyzed by 1,8-Diaza-bicyclo[5.4.0]undec-7-ene

Anion-Relay Double Aza-Michael-Michael Cascades to Enone-Tethered Cyclohexadienones: Access to an Intricate Bridged Ring System

Advances in synthesis of novel annulated azecines and their unique pharmacological properties

A Sonochemical and Mechanochemical One‐Pot Multicomponent/Click Coupling Strategy for the Sustainable Synthesis of Bis‐heterocyclic Drug Scaffolds

Enantioenriched Methylene-Bridged Benzazocanes Synthesis by Organocatalytic and Superacid Activations

The Divergent Synthesis of Nitrogen Heterocycles by Rhodium(Ii)-Catalyzed Cycloadditions of 1-Sulfonyl 1,2,3-Triazoles with 1,3-Dienes

Azetidines with All-Carbon Quaternary Centers: Merging Relay Catalysis with Strain Release Functionalization

Harnessing Oxetane and Azetidine Sulfonyl Fluorides for Opportunities in Drug Discovery

A ring expansion strategy towards diverse azaheterocycles

Synthesis of 3-Aminoazaindazoles via Cu-Catalyzed Cross Coupling of Isocyanides

Recent Achievements in the Rhodium‐Catalyzed Concise Construction of Medium N‐Heterocycles, Azepines and Azocines

Intermolecular Triazene Alkene Cycloaddition Via Lewis Base Catalysis: Access to Diverse Trifluoromethylated Pyrazolines.

Organocatalytic multicomponent strategy for synthesizing amalgamated triazole-benzimidazole/thiazole scaffolds and comprehensive evaluation of their ab initio behavior